Amarin Corp Plc (AMRN)

[Jasbg]

Looking at GSK -Teva case - it becomes interesting - looking at Hikma's - public data on the Internet:

Is there anywhere were a User from Hikma's official date - could actually find data that indicates the extended CDV benefits - And There Is'.
--------------------------------

Very obvious that the actual Label has been Cleaned Out for every possible CDV reference - but if you look a bit harder a reference to a 'CDV trial testing Icosapent Ethyl in Canada:

Under here the Official Product Information - that Hikma links to themselves from homepage:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e3d38d1d-fbe7-413d-849a-675e7dfa9b0a#section-10.1

When on this webpage press menu (left side) 'Clinical Trials'

https://www.clinicaltrials.gov/ct/search?submit=Search&term=ICOSAPENT

And - Viola - second trial in the list:

The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk

The Clever User with know CDV problems - will ask "Does that not remind me of something" - which other medicines holds Icosapent Ethyl (searching DailyMed):

https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ICOSAPENT+ETHYL

Naahh .. . Vascepa !